Citadel Advisors’s Amplify Treatments, Testing and Advancements ETF GERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $515K | Buy |
|
|||||
|
2024
Q1 | $298K | Sell |
|
|||||
|
2023
Q4 | $321K | Sell |
|
|||||
|
2023
Q3 | $330K | Sell |
|
|||||
|
2023
Q2 | $579K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $865K | Buy |
|
|||||
|
2022
Q3 | $619K | Buy |
|
|||||
|
2022
Q2 | $632K | Buy |
|
|||||
|
2022
Q1 | $668K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $347K | Sell |
|
|||||
|
2021
Q2 | $467K | Sell |
|
|||||
|
2021
Q1 | $1.09M | Buy |
|
|||||
|
2020
Q4 | $529K | Buy |
|
|||||
|
2020
Q3 | $213K | Buy |
|